株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アブレーション技術の世界市場 〜2021年:高周波、超音波 (ESWL/HIFU)、レーザー、電気 (アルゴンプラズマ、IRE)、凍結療法、マイクロ波、水熱

Ablation Technologies Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal), Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021

発行 MarketsandMarkets 商品コード 247577
出版日 ページ情報 英文 198 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。
Back to Top
アブレーション技術の世界市場 〜2021年:高周波、超音波 (ESWL/HIFU)、レーザー、電気 (アルゴンプラズマ、IRE)、凍結療法、マイクロ波、水熱 Ablation Technologies Market by Product (Radiofrequency, Ultrasound (ESWL, HIFU), Laser, Electrical (Argon Plasma, IRE), Cryotherapy, Microwave, Hydrothermal), Application (Cardiovascular, Cancer, Pain Management, Orthopedics) - Global Forecasts to 2021
出版日: 2017年02月24日 ページ情報: 英文 198 Pages
概要

世界のアブレーション技術市場は、2016〜2021年に10.9%ものCAGR (複合年間成長率) で成長し、2021年には47億3000万米ドルの規模に達する見込みとなっています。市場成長の主な要因として、アブレーション装置の件数増加や、新製品開発資金の増額、新興国市場 (中国・インド・メキシコなど) の成長などが挙げられます。製品別では、温度制御機能に優れた高周波 (RF) アブレータが最大のシェアを占めています。

当レポートでは、世界のアブレーション技術市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、タイプ別・製品別・用途別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場動態
    • 市場発展促進要因
      • 次世代アブレーション製品および技術の登場
      • 癌罹患率の上昇
      • 心血管疾患有病率の上昇
      • アブレーション処置件数の増加
      • 病院および外科手術/アブレーションセンターの件数増加
    • 市場発展阻害要因
      • 発展途上国における機器の再利用および再加工
      • 医療コスト抑制施策
      • 厳しい規制シナリオ
    • 市場機会
      • 新興国市場での成長可能性
      • アブレーション処置の知名度の上昇
    • 課題
      • 製品リコール
      • 治療における課題

第6章 産業動向

  • 業界の主な傾向:アブレーション市場
    • 業界再編
    • 多国籍企業の発展途上国への関心増大
    • アブレーション製品の開発・実用化向け資金の増額
    • マイクロ波アブレーション分野の顕著な発展
    • 最先端の高周波アブレーション装置の開発に対する、各企業の高い関心
  • 医療費償還シナリオ (質的調査)
  • サプライチェーン分析
  • ポーターのファイブフォース分析

第7章 世界のアブレーション技術市場、タイプ別

  • イントロダクション
  • 高周波アブレーション
  • レーザー/光アブレーション
  • 超音波アブレーション
  • 電気的アブレーション
  • 冷凍アブレーション
  • マイクロアブレーション
  • 水熱アブレーション

第8章 世界のアブレーション技術市場、製品別

  • イントロダクション
  • 高周波アブレーション
    • 温度制御式アブレータ (高周波発生装置)
    • 液冷式アブレータ
    • ロボット式カテーテル操作システム
  • レーザー/光アブレーション
    • エキシマレーザー・アブレータ
    • 低温レーザー・アブレータ
  • 超音波アブレーション
    • 超音波手術用アブレーションシステム
    • HIFU (高密度焦点式超音波治療法) アブレータ
    • ESWL (体外衝撃波砕石術) システム
    • MRgFUS (経頭蓋MRガイド下集束超音波治療) アブレータ
  • 電気的アブレーション
    • アルゴン・プラズマ/ビーム凝集装置
    • 不可逆的エレクトロポレーション (IRE) アブレーター
  • 冷凍アブレーション
    • 組織コンタクトプローブ
    • 組織スプレープローブ
    • 上皮性・皮下冷凍アブレーション装置
  • マイクロアブレーション
    • マイクロ波温熱療法装置
  • 水熱アブレーション
    • 子宮内膜用・温熱療法バルーンアブレーション装置

第9章 世界のアブレーション技術市場、用途別

  • イントロダクション
  • 心血管疾患治療
  • 癌治療
    • 肝臓癌
    • 腎臓癌
    • 前立腺癌
    • 肺癌
    • 骨転移
    • 乳癌
  • 眼科治療
  • 疼痛処理
  • 婦人科治療
  • 泌尿器治療
  • 整形外科治療
  • 美容整形/美顔整形手術
  • その他治療

第10章 世界のアブレーション技術市場、地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他アジア太平洋地域
  • 他の国々 (RoW)

第11章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 新製品発表・認可
    • 企業合併・買収 (M&A)
    • 他地域への進出
    • 協定、合弁事業
    • その他の動向

第12章 企業プロファイル

  • イントロダクション
  • MEDTRONIC PLC
  • BIOSENSE WEBSTER, INC. (JOHNSON & JOHNSON INC.の子会社)
  • ST. JUDE MEDICAL, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • ANGIODYNAMICS, INC.
  • ATRICURE, INC.
  • CONMED CORPORATION
  • オリンパス
  • SMITH & NEPHEW
  • GALIL MEDICAL INC. (BTG INTERNATIONAL LTD.により買収)

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2738

The global ablation technologies market is expected to reach USD 4.73 billion by 2021 at a CAGR of 10.9% from 2016 to 2021. The growth of the market is driven by factors such as the increasing number of ablation procedures, rising incidence of cancer, growing prevalence of cardiovascular diseases, and the emergence of next-generation ablation products and technologies. However, product recalls and therapeutic challenges of the ablation devices are problems faced by market players in the market. Increasing funding for the development of novel ablation devices and emerging markets such as China, India, and Mexico are creating opportunities for the players involved in the market.

In this report, the market has been segmented on the basis of product (light/laser ablators, radiofrequency ablators, electrical ablators, ultrasound ablators, microwave ablators, cryoablation devices, and hydrothermal ablators), type (light/laser, radiofrequency, electrical, ultrasound, microwave, cryoablation, and hydrothermal), application (cancer, cardiovascular, gynecological, ophthalmological, urological, orthopedic, pain management, and cosmetic surgery), and region (North America, Europe, APAC, and the RoW).

The radiofrequency ablators market is estimated to account for the largest share of the market in 2016, followed by the light/laser ablators market. Use of RF ablators in primary interventional therapy for the treatment of many cardiac arrhythmias is a key factor driving the segment. Better temperature control by RF ablators as compared to other ablation products (such as electrical and microwave ablators) and clinical advantages offered by temperature-controlled RF ablators over traditional ablation approaches are further supporting the growth of this segment.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the market in 2016, followed by Europe. The market in North America is primarily driven by various factors including the presence of a large number of ablation product manufacturers, a significant rate of adoption of ablation treatment, large patient population base, and continuously rising prevalence of chronic disorders such as cancer and heart diseases (especially atrial fibrillation).

The market consists of a number of big, medium-sized, and small companies. In 2015, the market was dominated by Medtronic, plc (Ireland), Biosense Webster, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.). Product launches, mergers & acquisitions, geographical expansions, agreements, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the market.

Research Coverage:

This report studies the ablation technologies market based on type, product, and application. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research report focuses on various levels of analysis-industry trends, market ranking of top players, and company profiles-which together discuss basic views on the competitive landscape, emerging and high-growth segments of the ablation technologies market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products and services offered by major players in the ablation technologies market. The report analyzes the market based on type, product, application, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the ablation technologies market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ablation technologies products across geographies
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the ablation technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the ablation technologies market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
    • 1.4.1. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. RESEARCH DESIGN
  • 2.3. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.3.1. SECONDARY RESEARCH
      • 2.3.1.1. Key data from secondary sources
    • 2.3.2. PRIMARY RESEARCH
      • 2.3.2.1. Key data from primary sources
    • 2.3.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. OPPORTUNITY INDICATORS
    • 2.4.1. DEMAND-SIDE ANALYSIS
      • 2.4.1.1. Incidence and prevalence of cancer
      • 2.4.1.2. Rapid growth of geriatric population
      • 2.4.1.3. Significant number of clinical researches in ablation
    • 2.4.2. SUPPLY-SIDE ANALYSIS
      • 2.4.2.1. Clinical trials by ablation technologies
      • 2.4.2.2. Number of new product launches: ablation market (2013-2016)
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL ABLATION TECHNOLOGY MARKET OVERVIEW
  • 4.2. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL ABLATION TECHNOLOGY MARKET
  • 4.3. GLOBAL ABLATION TECHNOLOGY MARKET, BY TYPE AND REGION
  • 4.4. GLOBAL ABLATION TECHNOLOGY MARKET, BY APPLICATION
  • 4.5. GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY PRODUCT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Emergence of next-generation ablation products and technologies
      • 5.2.1.2. Rising incidence of cancer
      • 5.2.1.3. Growing prevalence of cardiovascular diseases
      • 5.2.1.4. Increasing number of ablation procedures
      • 5.2.1.5. Increasing number of hospitals, surgical, and ablation centers
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Reuse and reprocessing of devices in developing countries
      • 5.2.2.2. Healthcare cost-containment measures
      • 5.2.2.3. Unfavorable regulatory scenario
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth Potential Offered by Emerging markets
      • 5.2.3.2. Rising awareness related to ablation procedures
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Product recalls
      • 5.2.4.2. Therapeutic challenges

6. INDUSTRY TRENDS

  • 6.1. KEY INDUSTRY TRENDS: ABLATION MARKET
    • 6.1.1. INDUSTRY CONSOLIDATION
    • 6.1.2. INCREASING FOCUS OF GLOBAL PLAYERS TOWARDS DEVELOPING NATIONS
    • 6.1.3. INCREASING FUNDING FOR ABLATION PRODUCT DEVELOPMENT AND COMMERCIALIZATION
    • 6.1.4. NOTABLE DEVELOPMENTS IN MICROWAVE ABLATION SEGMENT
    • 6.1.5. HIGH FOCUS OF MARKET PLAYERS TOWARDS DEVELOPMENT OF ADVANCED RADIOFREQUENCY ABLATION DEVICES
  • 6.2. REIMBURSEMENT SCENARIO (QUALITATIVE INSIGHTS)
  • 6.3. SUPPLY CHAIN ANALYSIS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT OF SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY

7. GLOBAL ABLATION TECHNOLOGY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. RADIOFREQUENCY ABLATION
  • 7.3. LASER/LIGHT ABLATION
  • 7.4. ULTRASOUND ABLATION
  • 7.5. ELECTRICAL ABLATION
  • 7.6. CRYOABLATION
  • 7.7. MICROWAVE ABLATION
  • 7.8. HYDROTHERMAL ABLATION

8. GLOBAL ABLATION TECHNOLOGY MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
  • 8.2. RADIOFREQUENCY ABLATORS
    • 8.2.1. TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
    • 8.2.2. FLUID-COOLED RADIOFREQUENCY ABLATORS
    • 8.2.3. ROBOTIC CATHETER MANIPULATION SYSTEMS
  • 8.3. LASER/LIGHT ABLATORS
    • 8.3.1. EXCIMER LASER ABLATORS
    • 8.3.2. COLD LASER ABLATORS
  • 8.4. ULTRASOUND ABLATORS
    • 8.4.1. ULTRASONIC SURGICAL ABLATION SYSTEMS
    • 8.4.2. HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) ABLATORS
    • 8.4.3. EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY (ESWL) SYSTEMS
    • 8.4.4. MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND (MRGFUS) ABLATORS
  • 8.5. ELECTRICAL ABLATORS
    • 8.5.1. ARGON PLASMA/BEAM COAGULATORS
    • 8.5.2. IRREVERSIBLE ELECTROPORATION ABLATORS
  • 8.6. CRYOABLATION DEVICES
    • 8.6.1. TISSUE CONTACT PROBES
    • 8.6.2. TISSUE SPRAY PROBES
    • 8.6.3. EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
  • 8.7. MICROWAVE ABLATORS
    • 8.7.1. MICROWAVE THERMOTHERAPY DEVICES
  • 8.8. HYDROTHERMAL ABLATORS
    • 8.8.1. ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

9. GLOBAL ABLATION TECHNOLOGY MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. CARDIOVASCULAR DISEASE
  • 9.3. CANCER
    • 9.3.1. LIVER CANCER
    • 9.3.2. KIDNEY CANCER
    • 9.3.3. PROSTATE CANCER
    • 9.3.4. LUNG CANCER
    • 9.3.5. BONE METASTASIS
    • 9.3.6. BREAST CANCER
  • 9.4. OPHTHALMOLOGY
  • 9.5. PAIN MANAGEMENT
  • 9.6. GYNECOLOGY
  • 9.7. UROLOGY
  • 9.8. ORTHOPEDICS
  • 9.9. COSMETIC/ AESTHETIC SURGERY
  • 9.10. OTHER TREATMENTS

10. GLOBAL ABLATION TECHNOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Significant volume of ablation procedures in the country
      • 10.2.1.2. Remarkable adoption of advanced ablation technology as compared to conventional technologies
      • 10.2.1.3. Availability of funding for development of novel ablation devices
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Rising focus of market players
      • 10.3.1.2. Large number of ongoing clinical trials
      • 10.3.1.3. Favorable healthcare reimbursement scenario
      • 10.3.1.4. Growing incidence of cancer and cardiovascular diseases
    • 10.3.2. FRANCE
      • 10.3.2.1. Availability of funding for development of novel ablation devices in the country
      • 10.3.2.2. Availability of training programs and reimbursement for certain products in France
    • 10.3.3. U.K.
      • 10.3.3.1. Large patient population base
      • 10.3.3.2. Availability of research funding
      • 10.3.3.3. Expanding presence of market players
      • 10.3.3.4. Government recommendations encouraging adoption of ablation technology
    • 10.3.4. REST OF EUROPE
      • 10.3.4.1. Rapidly increasing aging population in the region
      • 10.3.4.2. Increasing market penetration of leading ablation manufacturers in the region
      • 10.3.4.3. Prominent adoption of ablation in Italy
  • 10.4. ASIA-PACIFIC
      • 10.4.1.1. Increasing government initiatives in the region
      • 10.4.1.2. Awareness programs and conferences in APAC
      • 10.4.1.3. Rising focus of market players
    • 10.4.2. JAPAN
      • 10.4.2.1. Well-developed healthcare system
      • 10.4.2.2. Rising baby boomer population coupled with cancer incidence in the country
      • 10.4.2.3. Rising government focus towards the development of the medical device industry
    • 10.4.3. CHINA
      • 10.4.3.1. High incidence of target diseases and rapidly aging population
    • 10.4.4. INDIA
      • 10.4.4.1. Remarkable patient base in the country
      • 10.4.4.2. Improving Healthcare Infrastructure In The Country
      • 10.4.4.3. Rising focus of global players
    • 10.4.5. REST OF ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES & APPROVALS
    • 11.3.2. MERGERS & ACQUISITIONS
    • 11.3.3. GEOGRAPHICAL EXPANSIONS
    • 11.3.4. AGREEMENTS AND JOINT VENTURES
    • 11.3.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. MEDTRONIC PLC
  • 12.3. BIOSENSE WEBSTER, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON INC.)
  • 12.4. ST. JUDE MEDICAL, INC.
  • 12.5. BOSTON SCIENTIFIC CORPORATION
  • 12.6. ANGIODYNAMICS, INC.
  • 12.7. ATRICURE, INC.
  • 12.8. CONMED CORPORATION
  • 12.9. OLYMPUS CORPORATION
  • 12.10. SMITH & NEPHEW
  • 12.11. GALIL MEDICAL INC. (ACQUIRED BY BTG INTERNATIONAL LTD.)

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: CLINICAL RESEARCH STATUS BY ABLATION TECHNOLOGIES AS OF 2017*
  • TABLE 2: MAJOR MERGER & ACQUISITION ACTIVITIES IN THE ABLATION TECHNOLOGY INDUSTRY (2013-2016)
  • TABLE 3: GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 4: ABLATION TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: RADIOFREQUENCY ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: LASER/LIGHT ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: ULTRASOUND ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: ELECTRICAL ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: CRYOABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: MICROWAVE ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: HYDROTHERMAL ABLATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 13: RADIOFREQUENCY ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 14: RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: LASER/LIGHT ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 19: LASER/LIGHT ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: EXCIMER LASER ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: COLD LASER ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: ULTRASOUND ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 23: ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: ELECTRICAL ABLATORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 29: ELECTRICAL ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ARGON PLASMA/BEAM COAGULATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: IRREVERSIBLE ELECTROPORATION ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: CRYOABLATION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 33: CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: TISSUE CONTACT PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: TISSUE SPRAY PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: MICROWAVE ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: HYDROTHERMAL ABLATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 40: ABLATION TECHNOLOGY MARKET SIZE FOR CARDIOVASCULAR DISEASE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: ABLATION TECHNOLOGY MARKET SIZE FOR CANCER, BY REGION, 2014-2021(USD MILLION)
  • TABLE 42: ABLATION TECHNOLOGY MARKET SIZE FOR OPHTHALMOLOGY TREATMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: ABLATION TECHNOLOGY MARKET SIZE FOR PAIN MANAGEMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: CURRENTLY APPROVED FDA ABLATION TECHNOLOGY PRODUCTS FOR GYNECOLOGICAL TREATMENT
  • TABLE 45: ABLATION TECHNOLOGY MARKET SIZE FOR GYNECOLOGY TREATMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: ABLATION TECHNOLOGY MARKET SIZE FOR UROLOGY, BY REGION, 2014-2021(USD MILLION)
  • TABLE 47: ABLATION TECHNOLOGY MARKET SIZE FOR ORTHOPEDICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: ABLATION TECHNOLOGY MARKET SIZE FOR COSMETIC/ AESTHETIC SURGERY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 49: ABLATION TECHNOLOGY MARKET SIZE FOR OTHER TREATMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL ABLATION TECHNOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 54: U.S.: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 55: CANADA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: GERMANY: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: FRANCE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: U.K.: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: REST OF EUROPE: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: JAPAN: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: CHINA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: INDIA: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: REST OF APAC: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: TOP 5 NEW PRODUCT LAUNCHES & APPROVALS, 2012-2015
  • TABLE 73: MERGERS & ACQUISITIONS, 2013-2016
  • TABLE 74: GEOGRAPHICAL EXPANSIONS, 2014-2016
  • TABLE 75: TOP 3 AGREEMENTS AND JOINT VENTURES, 2013-2015
  • TABLE 76: TOP 5 OTHER DEVELOPMENTS, 2014-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL ABLATION TECHNOLOGY MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: RESEARCH METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: ESTIMATED NUMBER OF NEW CANCER CASES, BY 2020 (THOUSANDS)
  • FIGURE 6: POPULATION AGED 65 AND ABOVE, BY REGION (IN MILLION): 2015, 2030, AND 2050
  • FIGURE 7: CLINICAL RESEARCH STATUS IN THE ABLATION MARKET 2017*
  • FIGURE 8: NEW ABLATION PRODUCT LAUNCHES, 2013-2016
  • FIGURE 9: DATA TRIANGULATION METHODOLOGY
  • FIGURE 10: ABLATION TECHNOLOGY MARKET SIZE, BY TYPE (2016 VS. 2021)
  • FIGURE 11: ABLATION TECHNOLOGY MARKET SHARE, BY PRODUCT (2016 VS. 2021)
  • FIGURE 12: ABLATION TECHNOLOGY MARKET SIZE, BY APPLICATION (2016 VS. 2021)
  • FIGURE 13: ABLATION TECHNOLOGY MARKET SHARE, BY REGION (2016)
  • FIGURE 14: RISING INCIDENCES OF CANCER & CARDIAC DISEASES - PRIMARY DRIVER OF THE ABLATION TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: INDIA AND CHINA ARE THE MOST LUCRATIVE MARKETS FOR ABLATION PRODUCT MANUFACTURERS DURING THE FORECAST PERIOD
  • FIGURE 16: U.S. COMMANDED THE LARGEST SHARE OF THE ABLATION TECHNOLOGY MARKET IN 2016
  • FIGURE 17: CARDIOVASCULAR DISEASE TREATMENT SEGMENT TO DOMINATE THE ABLATION TECHNOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: GLOBAL ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20: GLOBAL PREVALENCE OF CANCER: EXPECTED TREND TILL 2020
  • FIGURE 21: ABLATION TECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 22: MICROWAVE ABLATION SEGMENT TO GROW AT THE HIGHEST CAGR DURING 2016 TO 2021
  • FIGURE 23: MICROWAVE ABLATOR IS THE FASTEST-GROWING SEGMENT IN THE GLOBAL ABLATION TECHNOLOGY MARKET
  • FIGURE 24: CARDIOVASCULAR DISEASE TREATMENT ABLATION MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 25: NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES, BY COUNTRY: 2013
  • FIGURE 26: GLOBAL ABLATION TECHNOLOGY MARKET SHARE, BY COUNTRY (2016-2021)
  • FIGURE 27: NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 28: EUROPE: ABLATION TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 29: ASIA-PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT
  • FIGURE 30: LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES & APPROVALS AS THEIR KEY GROWTH STRATEGY FROM 2013 TO 2016
  • FIGURE 31: GLOBAL ABLATION TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 32: NEW PRODUCT LAUNCHES & APPROVALS WAS THE KEY STRATEGY
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF TOP MARKET PLAYERS
  • FIGURE 34: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 35: JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • FIGURE 36: ST. JUDE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 37: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
  • FIGURE 39: ATRICURE, INC.: COMPANY SNAPSHOT
  • FIGURE 40: CONMED CORPORATION: COMPANY SNAPSHOT
  • FIGURE 41: OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: SMITH & NEPHEW: COMPANY SNAPSHOT
  • FIGURE 43: BTG INTERNATIONAL LTD. : COMPANY SNAPSHOT
Back to Top